BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25556603)

  • 1. A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
    Wang C; Hu J; Lu M; Gu H; Zhou X; Chen X; Zen K; Zhang CY; Zhang T; Ge J; Wang J; Zhang C
    Sci Rep; 2015 Jan; 5():7610. PubMed ID: 25556603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma.
    Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L
    Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
    Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
    J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a four-microRNA panel in serum for screening renal cell carcinoma.
    Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
    Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients.
    Wang C; Ding M; Xia M; Chen S; Van Le A; Soto-Gil R; Shen Y; Wang N; Wang J; Gu W; Wang X; Zhang Y; Zen K; Chen X; Zhang C; Zhang CY
    EBioMedicine; 2015 Oct; 2(10):1377-85. PubMed ID: 26629532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma.
    He T; Lu C; Gong W; Ge Z; Li R; Li X; Sun C; Li W; Long Q; Liu Q; Lai Y
    Front Biosci (Landmark Ed); 2024 May; 29(5):186. PubMed ID: 38812297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary-derived extracellular vesicle microRNAs as non-invasive diagnostic biomarkers for early-stage renal cell carcinoma.
    Zhang Y; Zhu YY; Chen Y; Zhang L; Wang R; Ding X; Zhang H; Zhang CY; Zhang C; Gu WJ; Wang C; Wang JJ
    Clin Chim Acta; 2024 Jan; 552():117672. PubMed ID: 37995985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
    Tusong H; Maolakuerban N; Guan J; Rexiati M; Wang WG; Azhati B; Nuerrula Y; Wang YJ
    Cancer Biomark; 2017; 18(1):79-85. PubMed ID: 27814278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
    Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
    J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
    Liu S; Deng X; Zhang J
    Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of tumor suppressor miR-20b-5p, miR-30a-5p, and miR-196a-5p as a serum diagnostic panel for renal cell carcinoma.
    Huang G; Li H; Wang J; Peng X; Liu K; Zhao L; Zhang C; Chen X; Lai Y; Ni L
    Pathol Res Pract; 2020 Nov; 216(11):153152. PubMed ID: 32823234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
    Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
    Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
    Fedorko M; Juracek J; Stanik M; Svoboda M; Poprach A; Buchler T; Pacik D; Dolezel J; Slaby O
    Biochem Med (Zagreb); 2017 Jun; 27(2):411-417. PubMed ID: 28694731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs.
    Oto J; Herranz R; Plana E; Sánchez-González JV; Pérez-Ardavín J; Hervás D; Fernández-Pardo Á; Cana F; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma.
    Fedorko M; Stanik M; Iliev R; Redova-Lojova M; Machackova T; Svoboda M; Pacik D; Dolezel J; Slaby O
    Int J Mol Sci; 2015 Sep; 16(10):23382-9. PubMed ID: 26426010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.